Certified by Founder
Lodge
SolasCure
start up
United Kingdom
- Cambridge
- 28/03/2023
- Series B
- $13,422,000
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
- Industry Biotechnology Research
- Website https://solascure.com/
- LinkedIn https://www.linkedin.com/company/solascure/
Related People
Sam BakriFounder
United Kingdom -
Cambridge, England
Experienced executive and entrepreneur in life sciences, founded and exited life sciences companies in biopharmaceutical and medical devices.
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)